Catalyst Pharmaceuticals Inc (CPRX)
SG&A Expense Growth
-7.68%
Quarterly · Period ending:
CPRX SG&A Expense Growth
Latest reported-7.68%period ending
Latest reported-7.68%period ending
CPRX Quarterly SG&A Growth (QoQ) (0.00% → -7.68%)
Latest values, visible window
High-resolution chart · PNG
CPRX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -7.6786% | |
| 12.5363% | |
| 3.3102% | |
| -2.0507% | |
| 6.1527% | |
| -3.6792% | |
| 12.6442% | |
| -13.226% | |
| 11.6614% | |
| 25.2563% | |
| 18.1857% | |
| -4.4485% | |
| 102.6043% | |
| 7.4657% | |
| 5.6588% | |
| -21.3755% | |
| 24.2156% | |
| 8.8373% | |
| 5.385% | |
| -9.3111% | |
| -4.7661% | |
| 33.7245% | |
| -7.831% | |
| 7.6554% | |
| -11.7994% | |
| 41.4168% | |
| -10.2354% | |
| 6.7874% | |
| 21.5146% | |
| 90.0618% | |
| 38.5097% | |
| -1.6216% | |
| 26.92% | |
| 31.5502% | |
| -7.3856% | |
| -7.3112% | |
| 24.9338% | |
| 5.1781% | |
| -38.409% | |
| -14.3281% | |
| 14.0283% | |
| 19.5118% | |
| -14.8746% | |
| 19.433% | |
| 21.4265% | |
| 30.7801% | |
| 37.2438% | |
| 17.3142% | |
| 18.9158% | |
| 44.7225% | |
| -15.3535% | |
| -14.946% | |
| -19.3952% | |
| 20.9556% | |
| 17.6298% | |
| -16.1222% | |
| -40.6631% | |
| 107.822% | |
| 5.0922% | |
| -20.0666% | |
| -5.6238% | |
| 59.6483% | |
| -23.6965% | |
| -12.3813% | |
| -1.8231% | |
| 40.9802% | |
| 12.4203% | |
| -45.6222% | |
| 39.07% | |
| 12.0682% | |
| -17.5117% | |
| -12.2156% | |
| 52.101% | |
| -5.9319% | |
| 2.964% | |
| -40.894% | |
| 30.1979% | |
| -49.0186% | |
| 813.9384% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |